Boehringer Ingelheim Pharmaceuticals, Inc.

FDA-inspected organization

Boehringer Ingelheim Pharmaceuticals, Inc. has been audited by the FDA 39 times between 2001 and 2024 across all 3 sites.


Documents

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2019

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2018

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2018

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Danbury | 2017

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2017

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Danbury | 2013

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2011

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Danbury | 2006

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2005

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | 2001

Out of stock

FDA 483 Boehringer Ingelheim Pharmaceuticals, Inc., Danbury | 2001

Out of stock